Cellular Engineering Technologies Inc.

Cellular Engineering Technologies, Inc. (CET) provides optimized reagents and human cell lines that address the technical and clinical challenges of developing next-generation cell therapies and regenerative medicines. We offer native, human recombinant growth factors and cytokines that are designed to generate maximum cellular response and bioavailability. Our portfolio of human somatic stem cells and induced pluripotent stem cells, programmed using our patented virus and oncogene-free methods, produce the safest and most scalable starting cell line for your research and manufacturing needs. We also leverage our human protein expression models to create custom protein and peptide sequences. Contact one of our application scientists today to discuss how our bioproduction and cell line engineering expertise can accelerate your drug discovery or IND-enabling activities.